Physician profile
Brian E Hill
NPI 1932208238
$507.91
in general payments reported to CMS, 2019-2025
15 companies · $56.98 in 2025
The $56.98 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $27.68 · 2021: $34.01 · 2022: $105 · 2023: $85.26 · 2024: $59.09 · 2025: $56.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $109.32 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $56.98 | 2025 | Aptra |
| Blue Earth Diagnostics | $53.91 | 2019-2021 | |
| Zyla Life Sciences, INC. | $44.62 | 2019 | |
| Endo Pharmaceuticals INC. | $39.88 | 2019-2023 | Aveed |
| Mission Pharmacal Company | $29.41 | 2022 | |
| Axonics, INC. | $26.22 | 2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $23.86 | 2024 | Prolaris |
| Janssen Pharmaceuticals, INC | $20.53 | 2024 | Spravato |
| Allergan, INC. | $19.97 | 2019 | |
| Karl Storz Endoscopy-America | $18.84 | 2023 | |
| Travere Therapeutics, INC. | $17.77 | 2020-2021 | |
| Medtronic, INC. | $16.35 | 2022 | |
| Coloplast Corp | $15.55 | 2023 | Titan |
| Olympus America INC. | $14.70 | 2024 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.